Reduction of Hepatosteatosis and Lipid Levels by an Adipose Differentiation-Related Protein Antisense Oligonucleotide

Gastroenterology

Volumn 132, Issue 5, 2007, Pages 1947-1954

  Imai, Yumi ^a   Varela, Gladys M ^a   Jackson, Malaka B ^a   Graham, Mark J ^b   Crooke, Rosanne M ^b   Ahima, Rexford S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOPHILIN; ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GLUCOSE HOMEOSTASIS; LIPID BLOOD LEVEL; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 34247641706     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.02.046     Document Type: Article

References (37)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
2. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 (2003) 960-967
3. Londos C., Sztalryd C., Tansey J.T., and Kimmel A.R. Role of PAT proteins in lipid metabolism. Biochimie 87 (2005) 45-49
4. Tansey J.T., Sztalryd C., Gruia-Gray J., Roush D.L., Zee J.V., Gavrilova O., Reitman M.L., Deng C.X., Li C., Kimmel A.R., and Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98 (2001) 6494-6499
5. Jiang H.P., and Serrero G. Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein. Proc Natl Acad Sci U S A 89 (1992) 7856-7860
6. Brasaemle D.L., Barber T., Wolins N.E., Serrero G., Blanchette-Mackie E.J., and Londos C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J Lipid Res 38 (1997) 2249-2263
7. Heid H.W., Moll R., Schwetlick I., Rackwitz H.R., and Keenan T.W. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res 294 (1998) 309-321
8. Gao J., and Serrero G. Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake. J Biol Chem 274 (1999) 16825-16830
9. Imamura M., Inoguchi T., Ikuyama S., Taniguchi S., Kobayashi K., Nakashima N., and Nawata H. ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblasts. Am J Physiol Endocrinol Metab 283 (2002) E775-E783
10. Larigauderie G., Furman C., Jaye M., Lasselin C., Copin C., Fruchart J.C., Castro G., and Rouis M. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 504-510
11. Schadinger S.E., Bucher N.L., Schreiber B.M., and Farmer S.R. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab 288 (2005) E1195-E1205
12. Dalen K.T., Ulven S.M., Arntsen B.M., Solaas K., and Nebb H.I. PPARalpha activators and fasting induce the expression of adipose differentiation-related protein in liver. J Lipid Res 47 (2006) 931-943
13. Motomura W., Inoue M., Ohtake T., Takahashi N., Nagamine M., Tanno S., Kohgo Y., and Okumura T. Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet. Biochem Biophys Res Commun 340 (2006) 1111-1118
14. Steiner S., Wahl D., Mangold B.L., Robison R., Raymackers J., Meheus L., Anderson N.L., and Cordier A. Induction of the adipose differentiation-related protein in liver of etomoxir-treated rats. Biochem Biophys Res Commun 218 (1996) 777-782
15. Magnusson B., Asp L., Bostrom P., Ruiz M., Stillemark-Billton P., Linden D., Boren J., and Olofsson S.O. Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins. Arterioscler Thromb Vasc Biol 26 (2006) 1566-1571
16. Chang B.H., Li L., Paul A., Taniguchi S., Nannegari V., Heird W.C., and Chan L. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol Cell Biol 26 (2006) 1063-1076
17. Sztalryd C., Bell M., Lu X., Mertz P., Hickenbottom S., Chang B.H., Chan L., Kimmel A.R., and Londos C. Functional compensation for adipose differentiation-related protein (ADFP) by TIP47 in an adfp null embryonic cell line. J Biol Chem 281 (2006) 34341-34348
18. Takahashi N., Patel H.R., Qi Y., Dushay J., and Ahima R.S. Divergent effects of leptin in mice susceptible or resistant to obesity. Horm Metab Res 34 (2002) 691-697
19. Takahashi N., Qi Y., Patel H.R., and Ahima R.S. A novel aminosterol reverses diabetes and fatty liver disease in obese mice. J Hepatol 41 (2004) 391-398
20. Yu X.X., Murray S.F., Pandey S.K., Booten S.L., Bao D., Song X.Z., Kelly S., Chen S., McKay R., Monia B.P., and Bhanot S. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 42 (2005) 362-371
21. Jiang G., Li Z., Liu F., Ellsworth K., Dallas-Yang Q., Wu M., Ronan J., Esau C., Murphy C., Szalkowski D., Bergeron R., Doebber T., and Zhang B.B. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1. J Clin Invest 115 (2005) 1030-1038
22. Savage D.B., Choi C.S., Samuel V.T., Liu Z.X., Zhang D., Wang A., Zhang X.M., Cline G.W., Yu X.X., Geisler J.G., Bhanot S., Monia B.P., and Shulman G.I. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest 116 (2006) 817-824
23. Crooke R.M., Graham M.J., Lemonidis K.M., Whipple C.P., Koo S., and Perera R.J. An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. J Lipid Res 46 (2005) 872-884
24. Qi Y., Takahashi N., Hileman S.M., Patel H.R., Berg A.H., Pajvani U.B., Scherer P.E., and Ahima R.S. Adiponectin acts in the brain to decrease body weight. Nat Med 10 (2004) 524-529
25. Millar J.S., Cromley D.A., McCoy M.G., Rader D.J., and Billheimer J.T. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J Lipid Res 46 (2005) 2023-2028
26. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., and Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11 (2005) 183-190
27. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
28. Qi Y., Nie Z., Lee Y.S., Singhal N.S., Scherer P.E., Lazar M.A., and Ahima R.S. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55 (2006) 3083-3090
29. Rajala M.W., Qi Y., Patel H.R., Takahashi N., Banerjee R., Pajvani U.B., Sinha M.K., Gingerich R.L., Scherer P.E., and Ahima R.S. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53 (2004) 1671-1679
30. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., and Lazar M.A. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
31. Wolins N.E., Brasaemle D.L., and Bickel P.E. A proposed model of fat packaging by exchangeable lipid droplet proteins. FEBS Lett 580 (2006) 5484-5491
32. Wolins N.E., Quaynor B.K., Skinner J.R., Schoenfish M.J., Tzekov A., and Bickel P.E. S3-12, Adipophilin, and TIP47 package lipid in adipocytes. J Biol Chem 280 (2005) 19146-19155
33. Martinez-Botas J., Anderson J.B., Tessier D., Lapillonne A., Chang B.H., Quast M.J., Gorenstein D., Chen K.H., and Chan L. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 26 (2000) 474-479
34. Saha P.K., Kojima H., Martinez-Botas J., Sunehag A.L., and Chan L. Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J Biol Chem 279 (2004) 35150-35158
35. Masuda Y., Itabe H., Odaki M., Hama K., Fujimoto Y., Mori M., Sasabe N., Aoki J., Arai H., and Takano T. ADRP/adipophilin is degraded through the proteasome-dependent pathway during regression of lipid-storing cells. J Lipid Res 47 (2006) 87-98
36. Dobrzyn A., and Ntambi J.M. Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes Rev 6 (2005) 169-174
37. Gutierrez-Juarez R., Pocai A., Mulas C., Ono H., Bhanot S., Monia B.P., and Rossetti L. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest 116 (2006) 1686-1695